Jonathan Gerber, MD from Levine Cancer Institute discusses new agents becoming available for the 1st time in decades and what agents can be safely combined in pre & post transplant therapy at the 2017 American Society of Hematology.
Jonathan Gerber, MD from Levine Cancer Institute discusses new agents becoming available for the 1st time in decades and what agents can be safely combined in pre & post transplant therapy at the 2017 American Society of Hematology.